K. A. "Ajay" Kumar Phd, Mba Email & Phone Number

Parsippany-Troy Hills, NJ, US

New Jersey

• Drug Development for all major focus therapeutic areas including Oncology, Immunology, CV, Diabetes and metabolic diseases, Urology etc.
• BusStim (Business Stimulus Consultants) works on assets that are usually brought in through partnership in the late-discovery/Pre-Clinical stage and then developed to Phase II/IIb clinical for an eventual Licensing to.
• BusStim (Business Stimulus Consultants) works on assets that are usually brought in through partnership in the late-discovery/Pre-Clinical stage and then developed to Phase II/IIb clinical for an eventual Licensing to.
• Managing team of over 40 top level consultants ranging in experience from the late discovery to market. Managing also partnership with CRO’s, Biotechs and other groups who form a part of the BusStim network.
• Licensing and Partnerships including comprehensive due-diligence which lie as the core of the BusStim’s Risk-Sharing drug development model. The goal being to take on assets for which there is an acute market/licensing.
• Overall Business Strategy from the near horizon operational strategy to long term business strategy.

• General Management, Strategy, In and Out-licensing, Budgets, Startups, Alliance management, Investor relationship, Financial valuation, Overall Project/Program Management, Projections/Forecasting and Team building
• Positioned and differentiated the company from the usual contract research spectrum by establishing the company as a center for excellence with capabilities in Drug Development (Pre-clinical to clinical) for.
• Positioned and differentiated the company from the usual contract research spectrum by establishing the company as a center for excellence with capabilities in Drug Development (Pre-clinical to clinical) for.
• Implemented a multi-year strategic plan, with the company turning operationally profitable within 12 months and an expected CAGR of greater than 100% for the first 4 years.
• Set up a lean and nimble operational team for projects, with the ability to bid for projects which would normally be off-shored. A multi-year project was signed with a major international client due to this initiative.
• Created a strategic alliance in the drug development area with an agency agreement established with a Pharma/Biotech company for developing their Rx oncology drug. Negotiation is at an advanced stage with an Investment.

Project/Program management and Drug development including selection and guiding drug candidates through the preclinical stages as well as the clinical phases. Managed iv and oral oncology agents from the pre-clinical to early clinical stages. Managed the out-licensing activities of drugs on behalf of Taxolog. Directed and managed a Drug Discovery group.

Managed the Acros process development group for Fisher. Transferred the technology developed, to the Fisher pilot plant and production facility in Europe. Involved from the technological angle into the activities/business strategy of Fisher in the areas of pharmaceutics and bio-technology. Managed IP transfer and utilization from the acqusition of the.

Mba, Finance

Activities and Societies: Beta Gamma Sigma-Business Honor Society

Ph. D, Organic Chemistry